Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from Reuters

13:19 EST 14th November 2018 | BioPortfolio

Here are the most relevant search results for "Reuters" found in our extensive news archives from over 250 global news sources.

More Information about Reuters on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Reuters for you to read. Along with our medical data and news we also list Reuters Clinical Trials, which are updated daily. BioPortfolio also has a large database of Reuters Companies for you to search.

Showing News Articles 1–25 of 2,700+ from Reuters

Wednesday 14th November 2018

French pharma group Ipsen closes in on its next drug deals

French drugmaker Ipsen plans to bring in multiple new medicines through a series of transactions and sees the recent price drop of biotech stocks as increasing deal opportunities, its chief executive said on Wednesday.

Merck cancer drug Keytruda succeeds in late-stage trial

U.S. drugmaker Merck & Co said on Wednesday its blockbuster cancer drug Keytruda met the main goal of a late-stage trial, of extending the lives of patients with cancers of the digestive tract.

Pfizer loses Lyrica drug patent fight in UK Supreme Court

Pfizer lost the final round in a long-running patent battle in Britain on Wednesday after the country's highest court ruled against it in a case involving its $5 billion-a-year pain drug Lyrica.

German health minister calls for faster adoption of biosimilar drugs

Germany's health minister Jens Spahn has called for faster adoption of cheaper copies of biotech drugs to treat cancer and autoimmune diseases to reign in rising public healthcare costs.

Merck drug Keytruda succeeds in late-stage esophageal cancer trial

Merck & Co's blockbuster drug Keytruda met the main goal of a late-stage trial testing the treatment in patients with cancers of the digestive tract, the U.S. drugmaker said on Wednesday.

In rural France, Macron seeks remedy for 'healthcare deserts'

When Joelle Dupas falls ill, she goes to a medical center in her home town in rural western France where all 12 doctors have come out of retirement.

Factbox: Macron's plan to fix France's healthcare system

French President Emmanuel Macron has promised extra money and more doctors to ease pressure on France's healthcare system.

Pfizer loses blockbuster drug patent fight in UK Supreme Court

Pfizer lost the final round in a long-running patent battle in Britain on Wednesday after the country's highest court ruled against it in a case involving its $5 billion-a-year pain drug Lyrica.

Tuesday 13th November 2018

Patients and industry fret over drug supplies, if no Brexit deal

Consumers and the pharmaceuticals industry alike are anxious about medicine supplies, if there is no deal on Britain's departure from the European Union.

U.S. physicians urge FDA to bolster labeling on high-sugar foods

The American Medical Association (AMA) is urging the U.S. Food and Drug Administration (FDA) to ramp up labeling of high-sugar foods, it said in a statement on Tuesday.

Most violent injuries seen in ER not reported to police

(Reuters Health) - The vast majority of violent injuries seen by doctors in emergency rooms are not reported to police, a new report suggests.

Many U.S. drugstores fail to provide naloxone for opioid overdoses

(Reuters Health) - Despite state laws expanding access to the opioid-overdose antidote naloxone without a prescription, two U.S. studies suggest many pharmacies don't stock the drug or make it easily available to people who need it.

Concussions tied to doubled risk of suicide

(Reuters Health) - Survivors of traumatic brain injuries may be more than twice as likely to die by suicide as individuals without a history of injuries like concussions or skull fractures, a research review suggests.

Juul Labs to pull sweet e-cigarette flavors to curb youth use

Juul Labs Inc, the U.S. market leader for electronic cigarettes, said Tuesday it will pull popular flavors such as mango, cucumber and fruit from retail store shelves in an effort to reduce surging teenage use of its products.

Obese kids less often demonstrate coping skills, academic interest

(Reuters Health) - Obese children may be less likely to meet a set of five markers for childhood flourishing that include academic and emotional skills, a new analysis of U.S. survey data suggests.

Mayo Clinic gets $200 million donation from turnaround expert Jay Alix

The Mayo Clinic on Tuesday said it received $200 million, the largest donation the academic medical center has ever received, from Jay Alix, founder of the consulting firm Alix Partners.

Congo's Ebola outbreak to last at least six more months: WHO

The Ebola outbreak in northeastern Democratic Republic of Congo, which has already killed more than 200 people, is expected to last until mid-2019, the World Health Organization's emergency response chief Peter Salama told reporters on Tuesday.

Juul Labs to pull sweet e-cig flavors to curb youth use

Juul Labs Inc, the U.S. market leader for electronic cigarettes, said on Tuesday it will pull popular flavors such as mango, cucumber and fruit from retail store shelves in an effort to reduce surging teenage use of its products.

Beekeeper therapist uses venom to heal his patients

On his rooftop in the outskirts of Cairo, Omar Abulhassan raises thousands of bees -- not for the honey, but their venom.

Express Scripts offers new formulary for lower list-price drugs

Express Scripts Holding Co on Tuesday announced a new drug reimbursement list with lower U.S. prices for brand-name medications, as a way to encourage drugmakers to move away from paying rebates after a prescription is filled. The manager of prescrip...

Walmart, Home Depot adopt health insurer tactic in drug copay battle

Walmart and Home Depot, two of the top 10 U.S. employers, have embraced a health insurance strategy that punishes drugmakers for using discount cards to keep patients from switching or stopping their medications.

China's Tangrenshen says African swine fever not found in its animal feed

Chinese animal feed maker Tangrenshen Group said on Tuesday that tests on feed made by one of its units had ruled out the presence of the deadly African swine fever.

African swine fever suspected to be in animal feed in China

(This Nov 11 story corrects headline and text throughout to say case of disease in feed was suspected, not confirmed. Removes paragraph, bullet saying it is first reported contamination of feed supply.)

Sobi buys rights to AstraZeneca infant drug for $1.5 billion upfront

AstraZeneca has taken another step to refocus on priority drugs by selling U.S. rights to a treatment for infant lung infections to Swedish Orphan Biovitrum for an upfront fee of $1.5 billion.

AstraZeneca sells infant drug rights to Sobi for $1.5 billion upfront

AstraZeneca took another step to refocus its portfolio on priority projects on Tuesday by selling U.S. rights to a treatment for a serious infant lung infection to Swedish Orphan Biovitrum for an upfront fee of $1.5 billion.


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks